BOOK
Pharmacology and the Nursing Process - E-Book
Linda Lane Lilley | Shelly Rainforth Collins | Julie S. Snyder
(2014)
Additional Information
Book Details
Abstract
With its colorful, user-friendly format, Pharmacology and the Nursing Process, 7th Edition provides students with all the pharmacology information they need — and no more than they need — to administer drugs safely and effectively. Increased emphasis on the nursing process and prioritization focuses on the most essential assessments, nursing diagnoses, interventions, and evaluations. Thoroughly updated drug information is clear and concise, highlighting the most commonly used drugs, and includes a unique focus on safety-oriented QSEN competencies. Hundreds of full-color illustrations show how drugs work in the body and depict key steps in drug administration. Written by expert pharmacology educators and clinicians, this bestselling textbook employs innovative, practical learning aids to help your students prepare for success on the NCLEX® Examination and in nursing practice.
- Focus on need-to-know information provides the most essential drug information for safe, effective clinical practice.
- Focus on the nursing process and prioritization helps you apply the nursing process to all aspects of drug therapy, from assessment to nursing diagnoses, interventions, and evaluation/outcome criteria.
- UNIQUE! Illustrated Study Skills Tips include practical advice on time management, note taking, study techniques, and test-taking strategies.
- Special boxes and tables highlight evidence-based practice, dosages, pharmacokinetics, laboratory values related to drug therapy, preventing medication errors, cultural implications, lifespan considerations, herbal therapies, and legal and ethical principles.
- Nearly 300 full-color illustrations and the Photo Atlas of Drug Administration show how drugs work in the body and depict key steps in drug administration by various routes.
- NCLEX® Examination−style review questions are included in every chapter, with at least one alternate-format item per chapter and more than 40 new dosage calculation questions.
- Drug profiles highlight the pharmacokinetics and unique variations of commonly used drugs.
- Case studies promote clinical reasoning skills related to nursing pharmacology.
- Patient Teaching Tips include key points to convey to patients, their families, and their caregivers.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| IFC\r | IFC | ||
| BRIEF CONTENTS | i | ||
| ABOUT THE AUTHORS | ii | ||
| Pharmacology and the Nursing Process | iii | ||
| Copyright | iv | ||
| CONTRIBUTORS TO TEACHING/LEARNING RESOURCES | v | ||
| REVIEWERS | vi | ||
| PREFACE | vii | ||
| ORGANIZATION | vii | ||
| NEW TO THIS EDITION | viii | ||
| ADDITIONAL TEACHING/LEARNING FEATURES | viii | ||
| SUPPLEMENTAL RESOURCES | ix | ||
| ACKNOWLEDGMENTS | ix | ||
| WE WELCOME YOUR FEEDBACK | x | ||
| PART 1 -\rPharmacology Basics | 1 | ||
| CHAPTER 1 - The Nursing Process And Drug Therapy | 6 | ||
| OVERVIEW OF THE NURSING PROCESS | 7 | ||
| ASSESSMENT | 7 | ||
| NURSING DIAGNOSES | 9 | ||
| PLANNING | 10 | ||
| IMPLEMENTATION | 11 | ||
| EVALUATION | 15 | ||
| Chapter 2 - Pharmacologic Principles | 17 | ||
| OVERVIEW | 19 | ||
| PHARMACEUTICS | 21 | ||
| PHARMACOKINETICS | 22 | ||
| PHARMACODYNAMICS | 30 | ||
| PHARMACOTHERAPEUTICS | 31 | ||
| PHARMACOGNOSY | 35 | ||
| PHARMACOECONOMICS | 35 | ||
| TOXICOLOGY | 35 | ||
| SUMMARY | 36 | ||
| Chapter 3 - Lifespan Considerations | 37 | ||
| DRUG THERAPY DURING PREGNANCY | 38 | ||
| DRUG THERAPY DURING BREASTFEEDING | 38 | ||
| CONSIDERATIONS FOR NEONATAL AND PEDIATRIC PATIENTS | 39 | ||
| CONSIDERATIONS FOR ELDERLY PATIENTS | 42 | ||
| NURSING PROCESS | 44 | ||
| Chapter 4 - Cultural, Legal, and Ethical Considerations | 50 | ||
| CULTURAL CONSIDERATIONS | 51 | ||
| LEGAL CONSIDERATIONS | 54 | ||
| ETHICAL CONSIDERATIONS | 59 | ||
| NURSING PROCESS | 60 | ||
| Chapter 5 - Medication Errors: Preventing and Responding | 64 | ||
| GENERAL IMPACT OF ERRORS ON PATIENTS | 65 | ||
| MEDICATION ERRORS | 65 | ||
| ISSUES CONTRIBUTING TO ERRORS | 66 | ||
| PREVENTING, RESPONDING TO, REPORTING, AND DOCUMENTING MEDICATION ERRORS: A NURSING PERSPECTIVE | 68 | ||
| OTHER ETHICAL ISSUES | 71 | ||
| SUMMARY | 72 | ||
| Chapter 6 - Patient Education and Drug Therapy | 74 | ||
| ASSESSMENT OF LEARNING NEEDS RELATED TO DRUG THERAPY | 75 | ||
| NURSING DIAGNOSES RELATED TO LEARNING NEEDS AND DRUG THERAPY | 77 | ||
| PLANNING RELATED TO LEARNING NEEDS AND DRUG THERAPY | 77 | ||
| IMPLEMENTATION RELATED TO PATIENT EDUCATION AND DRUG THERAPY | 77 | ||
| EVALUATION OF PATIENT LEARNING RELATED TO DRUG THERAPY | 81 | ||
| SUMMARY | 81 | ||
| Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary Supplements | 84 | ||
| OVER-THE-COUNTER DRUGS | 85 | ||
| HERBALS AND DIETARY SUPPLEMENTS | 87 | ||
| Chapter 8 - Gene Therapy and Pharmacogenomics | 94 | ||
| BASIC PRINCIPLES OF GENETIC INHERITANCE | 95 | ||
| DISCOVERY, STRUCTURE, AND FUNCTION OF DNA | 96 | ||
| GENE THERAPY | 97 | ||
| PHARMACOGENETICS AND PHARMACOGENOMICS | 98 | ||
| SUMMARY | 100 | ||
| Chapter 9 - Photo Atlas of Drug Administration | 102 | ||
| PREPARING FOR DRUG ADMINISTRATION | 102 | ||
| ENTERAL DRUGS | 104 | ||
| PARENTERAL DRUGS | 110 | ||
| TOPICAL DRUGS | 128 | ||
| ILLUSTRATION CREDITS | 136 | ||
| PART 2 - Drugs Affecting the Central Nervous System | 137 | ||
| Chapter 10 - Analgesic Drugs | 139 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 141 | ||
| TREATMENT OF PAIN IN SPECIAL SITUATIONS | 144 | ||
| PHARMACOLOGY OVERVIEW | 147 | ||
| OPIOID DRUGS | 147 | ||
| NONOPIOID AND MISCELLANEOUS ANALGESICS | 155 | ||
| Chapter 11 - General and Local Anesthetics | 169 | ||
| ANATOMY, PHYSIOLOGY, ANDÂ PATHOPHYSIOLOGY OVERVIEW | 170 | ||
| PHARMACOLOGY OVERVIEW | 170 | ||
| GENERAL ANESTHETICS | 170 | ||
| DRUGS FOR MODERATE SEDATION | 173 | ||
| LOCAL ANESTHETICS | 174 | ||
| NEUROMUSCULAR BLOCKING DRUGS | 177 | ||
| Chapter 12 - Central Nervous System Depressants and Muscle Relaxants | 188 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 189 | ||
| PHYSIOLOGY OF SLEEP | 189 | ||
| PHARMACOLOGY OVERVIEW | 190 | ||
| BENZODIAZEPINES AND MISCELLANEOUS HYPNOTIC DRUGS | 190 | ||
| BARBITURATES | 193 | ||
| MUSCLE RELAXANTS | 196 | ||
| Chapter 13 - Central Nervous System Stimulants and Related Drugs | 203 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 204 | ||
| ATTENTION DEFICIT HYPERACTIVITY DISORDER | 205 | ||
| NARCOLEPSY | 205 | ||
| OBESITY | 205 | ||
| MIGRAINE | 205 | ||
| ANALEPTIC-RESPONSIVE RESPIRATORY DEPRESSION SYNDROMES | 205 | ||
| PHARMACOLOGY OVERVIEW | 206 | ||
| DRUGS FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER AND NARCOLEPSY | 206 | ||
| ANOREXIANTS | 208 | ||
| ANTIMIGRAINE DRUGS | 209 | ||
| DRUGS FOR SPECIFIC RESPIRATORY DEPRESSION SYNDROMES: ANALEPTICS | 212 | ||
| Chapter 14 - Antiepileptic Drugs | 219 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 220 | ||
| EPILEPSY | 220 | ||
| PHARMACOLOGY OVERVIEW | 221 | ||
| ANTIEPILEPTIC DRUGS | 221 | ||
| Chapter 15 - Antiparkinson Drugs | 237 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 238 | ||
| PATHOPHYSIOLOGY OF PARKINSON’S DISEASE | 238 | ||
| TREATMENT OF PARKINSON’S DISEASE | 239 | ||
| PHARMACOLOGY OVERVIEW | 240 | ||
| MONOAMINE OXIDASE INHIBITORS | 240 | ||
| DRUG PROFILES | 242 | ||
| DOPAMINE MODULATOR | 243 | ||
| DRUG PROFILE | 243 | ||
| CATECHOL ORTHO-METHYLTRANSFERASE INHIBITORS | 243 | ||
| DRUG PROFILE | 244 | ||
| NONDOPAMINE DOPAMINE RECEPTOR AGONISTS | 244 | ||
| DRUG PROFILES | 244 | ||
| DOPAMINE REPLACEMENT DRUGS | 245 | ||
| ANTICHOLINERGIC DRUGS | 246 | ||
| Chapter 16 - Psychotherapeutic Drugs | 253 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 254 | ||
| PHARMACOLOGY OVERVIEW | 256 | ||
| ANXIOLYTIC DRUGS | 256 | ||
| MOOD-STABILIZING DRUGS | 259 | ||
| ANTIDEPRESSANT DRUGS | 259 | ||
| TRICYCLIC ANTIDEPRESSANTS | 261 | ||
| MONOAMINE OXIDASE INHIBITORS | 264 | ||
| SECOND-GENERATION ANTIDEPRESSANTS | 265 | ||
| ANTIPSYCHOTIC DRUGS | 267 | ||
| Chapter 17 - Substance Abuse | 281 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 282 | ||
| PHARMACOLOGY OVERVIEW | 283 | ||
| OPIOIDS | 283 | ||
| STIMULANTS | 284 | ||
| DEPRESSANTS | 285 | ||
| ALCOHOL | 287 | ||
| NICOTINE | 289 | ||
| PART 3 -\rDrugs Affecting the Autonomic Nervous System | 296 | ||
| Chapter 18 - Adrenergic Drugs | 298 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 299 | ||
| SYMPATHETIC NERVOUS SYSTEM | 299 | ||
| PHARMACOLOGY OVERVIEW | 300 | ||
| ADRENERGIC DRUGS | 300 | ||
| Chapter 19 - Adrenergic-Blocking Drugs | 312 | ||
| OBJECTIVES | 312 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 313 | ||
| PHARMACOLOGY OVERVIEW | 313 | ||
| ALPHA BLOCKERS | 313 | ||
| DRUG PROFILES | 316 | ||
| BETA BLOCKERS | 316 | ||
| DRUG PROFILES | 318 | ||
| NURSING PROCESS | 319 | ||
| Anchor 76 | 322 | ||
| Anchor 77 | 323 | ||
| Chapter 20 - Cholinergic Drugs | 324 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 325 | ||
| PARASYMPATHETIC NERVOUS SYSTEM | 325 | ||
| PHARMACOLOGY OVERVIEW | 325 | ||
| CHOLINERGIC DRUGS | 325 | ||
| Chapter 21 - Cholinergic-Blocking Drugs | 334 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 335 | ||
| PARASYMPATHETIC NERVOUS SYSTEM | 335 | ||
| PHARMACOLOGY OVERVIEW | 335 | ||
| CHOLINERGIC-BLOCKING DRUGS | 335 | ||
| PART 4 -\rDrugs Affecting the\rCardiovascular and\rRenal Systems | 343 | ||
| CHAPTER 22 - ANTIHYPERTENSIVE DRUGS | 347 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 348 | ||
| PHARMACOLOGY OVERVIEW | 349 | ||
| REVIEW OF AUTONOMIC NEUROTRANSMISSION | 350 | ||
| ADRENERGIC DRUGS | 350 | ||
| ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS | 353 | ||
| ANGIOTENSIN II RECEPTOR BLOCKERS | 356 | ||
| CALCIUM CHANNEL BLOCKERS | 357 | ||
| DIURETICS | 357 | ||
| VASODILATORS | 357 | ||
| MISCELLANEOUS ANTIHYPERTENSIVE DRUGS | 359 | ||
| Chapter 23 - Antianginal Drugs | 368 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 369 | ||
| PHARMACOLOGY OVERVIEW | 369 | ||
| NITRATES AND NITRITES | 370 | ||
| BETA BLOCKERS | 372 | ||
| CALCIUM CHANNEL BLOCKERS | 374 | ||
| MISCELLANEOUS ANTIANGINAL DRUG | 376 | ||
| SUMMARY OF ANTIANGINAL PHARMACOLOGY | 376 | ||
| Chapter 24 - Heart Failure Drugs | 382 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 383 | ||
| PHARMACOLOGY OVERVIEW | 384 | ||
| ANGIOTENSIN-CONVERTING ENZYME INHIBITORS | 384 | ||
| ANGIOTENSIN II RECEPTOR BLOCKERS | 385 | ||
| BETA BLOCKERS | 385 | ||
| ALDOSTERONE ANTAGONISTS | 385 | ||
| MISCELLANEOUS HEART FAILURE DRUGS | 385 | ||
| B-TYPE NATRIURETIC PEPTIDE | 386 | ||
| PHOSPHODIESTERASE INHIBITORS | 387 | ||
| CARDIAC GLYCOSIDES | 387 | ||
| Chapter 25 - Antidysrhythmic Drugs | 396 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 397 | ||
| DYSRHYTHMIAS AND NORMAL CARDIAC ELECTROPHYSIOLOGY | 397 | ||
| PHARMACOLOGY OVERVIEW | 403 | ||
| ANTIDYSRHYTHMIC DRUGS | 403 | ||
| Chapter 26 - Coagulation Modifier Drugs | 418 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 419 | ||
| PHARMACOLOGY OVERVIEW | 421 | ||
| ANTICOAGULANTS | 421 | ||
| ANTIPLATELET DRUGS | 427 | ||
| THROMBOLYTIC DRUGS | 430 | ||
| ANTIFIBRINOLYTIC DRUGS | 432 | ||
| Chapter 27 - Antilipemic Drugs | 443 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 444 | ||
| LIPIDS AND LIPID ABNORMALITIES | 444 | ||
| ATHEROSCLEROTIC PLAQUE FORMATION | 446 | ||
| CHOLESTEROL AND CORONARY HEART DISEASE | 446 | ||
| HYPERLIPIDEMIAS AND TREATMENT GUIDELINES | 446 | ||
| PHARMACOLOGY OVERVIEW | 448 | ||
| HYDROXYMETHYLGLUTARYL–COENZYME A REDUCTASE INHIBITORS | 448 | ||
| BILE ACID SEQUESTRANTS | 450 | ||
| NIACIN | 451 | ||
| FIBRIC ACID DERIVATIVES | 452 | ||
| Chapter 28 - Diuretic Drugs | 459 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 460 | ||
| PHARMACOLOGY OVERVIEW | 461 | ||
| CARBONIC ANHYDRASE INHIBITORS | 461 | ||
| LOOP DIURETICS | 462 | ||
| OSMOTIC DIURETICS | 464 | ||
| POTASSIUM-SPARING DIURETICS | 465 | ||
| THIAZIDES AND THIAZIDE-LIKE DIURETICS | 466 | ||
| Chapter 29 - Fluids and Electrolytes | 473 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 474 | ||
| PHARMACOLOGY OVERVIEW | 476 | ||
| CRYSTALLOIDS | 476 | ||
| COLLOIDS | 478 | ||
| BLOOD PRODUCTS | 479 | ||
| PHYSIOLOGY OF ELECTOLYTE BALANCE | 480 | ||
| POTASSIUM | 480 | ||
| SODIUM | 482 | ||
| PART 5 - Drugs Affecting the\rEndocrine System | 491 | ||
| Chapter 30 - Pituitary Drugs | 493 | ||
| ANATOMY, PHYSIOLOGY AND PATHOPHYSIOLOGY OVERVIEW | 494 | ||
| ENDOCRINE SYSTEM | 494 | ||
| PHARMACOLOGY OVERVIEW | 494 | ||
| PITUITARY DRUGS | 494 | ||
| Chapter 31 - Thyroid and Antithyroid Drugs | 501 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 502 | ||
| THYROID FUNCTION | 502 | ||
| PATHOPHYSIOLOGY OF HYPOTHYROIDISM | 502 | ||
| PATHOPHYSIOLOGY OF HYPERTHYROIDISM | 502 | ||
| PHARMACOLOGY OVERVIEW | 502 | ||
| THYROID REPLACEMENT DRUGS | 502 | ||
| ANTITHYROID DRUGS | 504 | ||
| Chapter 32 - Antidiabetic Drugs | 510 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 511 | ||
| PANCREAS | 511 | ||
| PATHOPHYSIOLOGY OF DIABETES MELLITUS | 512 | ||
| PHARMACOLOGY OVERVIEW | 516 | ||
| BIGUANIDE | 520 | ||
| SULFONYLUREAS | 521 | ||
| GLINIDES | 521 | ||
| THIAZOLIDINEDIONES (GLITAZONES) | 522 | ||
| ALPHA-GLUCOSIDASE INHIBITORS | 522 | ||
| DIPEPTIDYL PEPTIDASE IV (DPP-IV) INHIBITORS | 523 | ||
| AMYLIN AGONISTS | 524 | ||
| INCRETIN MIMETICS | 524 | ||
| Chapter 33 - Adrenal Drugs | 533 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 534 | ||
| ADRENAL SYSTEM | 534 | ||
| PHARMACOLOGY OVERVIEW | 535 | ||
| ADRENAL DRUGS | 535 | ||
| Chapter 34 - Women’s Health Drugs | 543 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 544 | ||
| FEMALE REPRODUCTIVE FUNCTIONS | 544 | ||
| PHARMACOLOGY OVERVIEW | 545 | ||
| ESTROGENS | 545 | ||
| PROGESTINS | 549 | ||
| FERTILITY DRUGS | 554 | ||
| UTERINE STIMULANTS | 555 | ||
| DRUGS FOR PRETERM LABOR MANAGEMENT | 557 | ||
| Chapter 35 - Men’s Health Drugs | 564 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 565 | ||
| MALE REPRODUCTIVE SYSTEM | 565 | ||
| PHARMACOLOGY OVERVIEW | 565 | ||
| ANDROGENS AND OTHER DRUGS PERTAINING TO MEN’S HEALTH | 565 | ||
| PART 6 - Drugs Affecting the Respiratory System | 573 | ||
| Chapter 36 - Antihistamines, Decongestants, Antitussives, and Expectorants | 575 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 576 | ||
| PHARMACOLOGY OVERVIEW | 576 | ||
| ANTIHISTAMINES | 576 | ||
| DECONGESTANTS | 580 | ||
| ANTITUSSIVES | 582 | ||
| EXPECTORANTS | 584 | ||
| Chapter 37 - Respiratory Drugs | 588 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 589 | ||
| PATHOPHYSIOLOGY OF DISEASES OF THE RESPIRATORY SYSTEM | 589 | ||
| TREATMENT OF DISEASES OF THE LOWER RESPIRATORY TRACT | 591 | ||
| PHARMACOLOGY OVERVIEW | 591 | ||
| BETA-ADRENERGIC AGONISTS | 591 | ||
| ANTICHOLINERGICS | 594 | ||
| XANTHINE DERIVATIVES | 595 | ||
| LEUKOTRIENE RECEPTOR ANTAGONISTS | 596 | ||
| CORTICOSTEROIDS | 597 | ||
| PHOSPHODIESTERASE-4 INHIBITOR | 600 | ||
| MONOCLONAL ANTIBODY ANTIASTHMATIC | 600 | ||
| PART 7 - Antiinfective and\rAntiinflammatory Drugs | 607 | ||
| Chapter 38 - Antibiotics Part 1 | 609 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 610 | ||
| MICROBIAL INFECTION | 610 | ||
| PHARMACOLOGY OVERVIEW | 612 | ||
| SULFONAMIDES | 614 | ||
| PENICILLINS | 616 | ||
| CEPHALOSPORINS | 619 | ||
| CARBAPENEMS | 623 | ||
| MONOBACTAMS | 623 | ||
| Chapter 39 - Antibiotics Part 2 | 633 | ||
| PATHOPHYSIOLOGY OF RESISTANT INFECTIONS | 634 | ||
| PHARMACOLOGY OVERVIEW | 635 | ||
| AMINOGLYCOSIDES | 635 | ||
| QUINOLONES | 638 | ||
| MISCELLANEOUS ANTIBIOTICS | 640 | ||
| Chapter 40 - Antiviral Drugs | 650 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 651 | ||
| GENERAL PRINCIPLES OF VIROLOGY | 651 | ||
| OVERVIEW OF VIRAL ILLNESSES AND THEIR TREATMENT | 653 | ||
| HERPES SIMPLEX VIRUS AND VARICELLA-ZOSTER VIRUS INFECTIONS | 654 | ||
| PHARMACOLOGY OVERVIEW | 655 | ||
| ANTIVIRALS (NON-HIV) | 655 | ||
| PATHOPHYSIOLOGY OVERVIEW | 658 | ||
| HIV INFECTION AND AIDS | 658 | ||
| PHARMACOLOGY OVERVIEW | 662 | ||
| DRUGS USED TO TREAT HIV INFECTION | 662 | ||
| PATHOPHYSIOLOGY OVERVIEW | 666 | ||
| OTHER VIRAL INFECTIONS | 666 | ||
| Chapter 41 - Antitubercular Drugs | 672 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 673 | ||
| PATHOPHYSIOLOGY OF TUBERCULOSIS | 673 | ||
| PHARMACOLOGY OVERVIEW | 674 | ||
| ANTITUBERCULAR DRUGS | 674 | ||
| Chapter 42 - Antifungal Drugs | 682 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 683 | ||
| FUNGAL INFECTIONS | 683 | ||
| PHARMACOLOGY OVERVIEW | 683 | ||
| ANTIFUNGAL DRUGS | 683 | ||
| Chapter 43 - Antimalarial, Antiprotozoal, and Anthelmintic Drugs | 692 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 693 | ||
| PATHOPHYSIOLOGY OF MALARIA | 693 | ||
| PHARMACOLOGY OVERVIEW | 693 | ||
| ANTIMALARIAL DRUGS | 693 | ||
| PATHOPHYSIOLOGY OVERVIEW | 698 | ||
| OTHER PROTOZOAL INFECTIONS | 698 | ||
| PHARMACOLOGY OVERVIEW | 698 | ||
| ANTIPROTOZOAL DRUGS | 698 | ||
| PATHOPHYSIOLOGY OVERVIEW | 700 | ||
| HELMINTHIC INFECTIONS | 700 | ||
| PHARMACOLOGY OVERVIEW | 701 | ||
| ANTHELMINTIC DRUGS | 701 | ||
| Chapter 44 - Antiinflammatory and Antigout Drugs | 706 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 707 | ||
| PHARMACOLOGY OVERVIEW | 707 | ||
| NONSTEROIDAL ANTIINFLAMMATORY DRUGS | 707 | ||
| ANTIGOUT DRUGS | 713 | ||
| PART 8 - Immune and Biologic Modifiers\rand Chemotherapeutic Drugs | 720 | ||
| CHAPTER 45 - ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC DRUGS | 722 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 724 | ||
| ETIOLOGY OF CANCER | 725 | ||
| PHARMACOLOGY OVERVIEW | 728 | ||
| ANTIMETABOLITES | 730 | ||
| MITOTIC INHIBITORS | 734 | ||
| ALKALOID TOPOISOMERASE II INHIBITORS | 735 | ||
| TOPOISOMERASE I INHIBITORS | 736 | ||
| ANTINEOPLASTIC ENZYMES | 738 | ||
| Chapter 46 - Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs | 748 | ||
| PHARMACOLOGY OVERVIEW | 749 | ||
| ALKYLATING DRUGS | 749 | ||
| DRUG PROFILES | 752 | ||
| CYTOTOXIC ANTIBIOTICS | 752 | ||
| Chapter 47 - Biologic Response–Modifying and Antirheumatic Drugs | 762 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 764 | ||
| OVERVIEW OF IMMUNOMODULATORS | 764 | ||
| IMMUNE SYSTEM | 764 | ||
| PHARMACOLOGY OVERVIEW | 766 | ||
| HEMATOPOIETIC DRUGS | 766 | ||
| INTERFERONS | 768 | ||
| MONOCLONAL ANTIBODIES | 770 | ||
| INTERLEUKINS AND RELATED DRUGS | 774 | ||
| MISCELLANEOUS IMMUNOMODULATING DRUGS | 776 | ||
| PATHOPHYSIOLOGY OVERVIEW | 776 | ||
| RHEUMATOID ARTHRITIS | 776 | ||
| PHARMACOLOGY OVERVIEW | 777 | ||
| DISEASE-MODIFYING ANTIRHEUMATIC ARTHRITIS DRUGS | 777 | ||
| Chapter 48 - Immunosuppressant Drugs | 784 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY DISEASE OVERVIEW | 785 | ||
| IMMUNE SYSTEM | 785 | ||
| PHARMACOLOGY OVERVIEW | 785 | ||
| IMMUNOSUPPRESSANT DRUGS | 785 | ||
| Chapter 49 - Immunizing Drugs and Biochemical Terrorism | 795 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 797 | ||
| IMMUNITY AND IMMUNIZATION | 797 | ||
| PHARMACOLOGY OVERVIEW | 799 | ||
| IMMUNIZING DRUGS | 799 | ||
| ANTHRAX | 808 | ||
| PART 9 - Drugs Affecting the\rGastrointestinal System\rand Nutrition | 813 | ||
| CHAPTER 50 - ACID-CONTROLLING DRUGS | 815 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 816 | ||
| ACID-RELATED PATHOPHYSIOLOGY | 816 | ||
| PHARMACOLOGY OVERVIEW | 818 | ||
| ANTACIDS | 818 | ||
| H2 RECEPTOR ANTAGONISTS | 820 | ||
| PROTON PUMP INHIBITORS | 822 | ||
| MISCELLANEOUS ACID-CONTROLLING DRUGS | 823 | ||
| Chapter 51 - Bowel Disorder Drugs | 829 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 830 | ||
| PHARMACOLOGY OVERVIEW | 830 | ||
| ANTIDIARRHEALS | 830 | ||
| LAXATIVES | 833 | ||
| DRUGS FOR IRRITABLE BOWEL SYNDROME | 838 | ||
| Chapter 52 - Antiemetic and Antinausea Drugs | 844 | ||
| NAUSEA AND VOMITING | 845 | ||
| PHARMACOLOGY OVERVIEW | 846 | ||
| ANTIEMETIC DRUGS | 846 | ||
| Chapter 53 - Vitamins and Minerals | 856 | ||
| ANATOMY, PHYSIOLOGY AND PATHOPHYSIOLOGY OVERVIEW | 857 | ||
| PHARMACOLOGY OVERVIEW | 857 | ||
| VITAMIN A | 859 | ||
| VITAMIN D | 861 | ||
| VITAMIN E | 863 | ||
| VITAMIN K | 863 | ||
| VITAMIN B1 | 865 | ||
| VITAMIN B2 | 865 | ||
| VITAMIN B3 | 866 | ||
| VITAMIN B6 | 867 | ||
| VITAMIN B12 | 867 | ||
| VITAMIN C | 869 | ||
| CALCIUM | 869 | ||
| MAGNESIUM | 871 | ||
| PHOSPHORUS | 872 | ||
| ZINC | 873 | ||
| Chapter 54 - Anemia Drugs | 877 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 878 | ||
| ERYTHROPOIESIS | 878 | ||
| TYPES OF ANEMIA | 878 | ||
| PHARMACOLOGY OVERVIEW | 880 | ||
| ERYTHROPOIESIS STIMULATING AGENTS | 880 | ||
| IRON | 880 | ||
| FOLIC ACID | 883 | ||
| OTHER ANEMIA DRUGS | 884 | ||
| Chapter 55 - Nutritional Supplements | 888 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 889 | ||
| PHARMACOLOGY OVERVIEW | 890 | ||
| PERIPHERAL TOTAL PARENTERAL NUTRITION | 892 | ||
| CENTRAL TOTAL PARENTERAL NUTRITION | 893 | ||
| TRACE ELEMENTS | 895 | ||
| PART 10 -\rDermatologic, Ophthalmic, and Otic Drugs | 899 | ||
| CHAPTER 56 - DERMATOLOGIC DRUGS | 901 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 902 | ||
| PHARMACOLOGY OVERVIEW | 903 | ||
| GENERAL ANTIBACTERIAL DRUGS | 904 | ||
| ANTIACNE DRUGS | 905 | ||
| ANTIFUNGAL DRUGS | 906 | ||
| ANTIVIRAL DRUGS | 907 | ||
| TOPICAL ANESTHETICS | 908 | ||
| TOPICAL ANTIPRURITICS AND ANTIINFLAMMATORIES | 908 | ||
| ANTIPSORIATIC DRUGS | 909 | ||
| MISCELLANEOUS DERMATOLOGIC DRUGS | 909 | ||
| Chapter 57 - Ophthalmic Drugs | 916 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 917 | ||
| LACRIMAL GLANDS | 919 | ||
| LAYERS OF THE EYE | 919 | ||
| PATHOPHYSIOLOGY OF GLAUCOMA | 920 | ||
| PHARMACOLOGY OVERVIEW | 921 | ||
| CHOLINERGIC DRUGS (MIOTICS) | 921 | ||
| SYMPATHOMIMETICS (MYDRIATICS) | 923 | ||
| BETA-ADRENERGIC BLOCKERS | 925 | ||
| CARBONIC ANHYDRASE INHIBITORS | 926 | ||
| OSMOTIC DIURETICS | 927 | ||
| PROSTAGLANDIN AGONISTS | 927 | ||
| Chapter 58 - Otic Drugs | 937 | ||
| ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY OVERVIEW | 937 | ||
| PHARMACOLOGY OVERVIEW | 938 | ||
| TREATMENT OF EAR DISORDERS | 938 | ||
| ANTIBACTERIAL AND ANTIFUNGAL OTIC DRUGS | 939 | ||
| EARWAX EMULSIFIERS | 939 | ||
| Appendix - Pharmaceutical Abbreviations | 943 | ||
| CASE STUDY PHOTO CREDITS | 944 | ||
| INDEX | 945 | ||
| EVIDENCE-BASED PRACTICE | 974 | ||
| PATIENT-CENTERED CARE: CULTURAL IMPLICATIONS | 974 | ||
| PATIENT-CENTERED CARE: LIFESPAN CONSIDERATIONS FOR THE ELDERLY PATIENT | 974 | ||
| PATIENT-CENTERED CARE: LIFESPAN CONSIDERATIONS FOR THE PEDIATRIC PATIENT | 974 | ||
| SAFETY: HERBAL THERAPIES AND DIETARY SUPPLEMENTS | 974 | ||
| SAFETY: LABORATORY VALUES RELATEDTO DRUG THERAPY | 975 | ||
| SAFETY AND QUALITY IMPROVEMENT: PREVENTING MEDICATION ERRORS | 975 | ||
| TEAMWORK AND COLLABORATION: LEGAL AND ETHICAL PRINCIPLES | 975 | ||
| ABBREVIATIONS FOR DIAGNOSTICAND LABORATORY TESTS | 975 | ||
| BIBLIOGRAPHY | 976 | ||
| CHAPTER 1 | 976 | ||
| CHAPTER 2 | 976 | ||
| CHAPTER 3 | 976 | ||
| CHAPTER 4 | 977 | ||
| CHAPTER 5 | 977 | ||
| CHAPTER 6 | 978 | ||
| CHAPTER 7 | 978 | ||
| CHAPTER 8 | 979 | ||
| CHAPTER 9 | 979 | ||
| CHAPTER 10 | 980 | ||
| CHAPTER 11 | 981 | ||
| CHAPTER 12 | 981 | ||
| CHAPTER 13 | 981 | ||
| CHAPTER 14 | 981 | ||
| CHAPTER 15 | 982 | ||
| CHAPTER 16 | 982 | ||
| CHAPTER 17 | 983 | ||
| CHAPTER 18 | 983 | ||
| CHAPTER 19 | 983 | ||
| CHAPTER 20 | 983 | ||
| CHAPTER 21 | 983 | ||
| CHAPTER 22 | 984 | ||
| CHAPTER 23 | 984 | ||
| CHAPTER 24 | 984 | ||
| CHAPTER 25 | 985 | ||
| CHAPTER 26 | 985 | ||
| CHAPTER 27 | 985 | ||
| CHAPTER 28 | 986 | ||
| CHAPTER 29 | 986 | ||
| CHAPTER 30 | 986 | ||
| CHAPTER 31 | 986 | ||
| CHAPTER 32 | 986 | ||
| CHAPTER 33 | 987 | ||
| CHAPTER 34 | 987 | ||
| CHAPTER 35 | 987 | ||
| CHAPTER 36 | 987 | ||
| CHAPTER 37 | 987 | ||
| CHAPTER 38 | 988 | ||
| CHAPTER 39 | 988 | ||
| CHAPTER 40 | 988 | ||
| CHAPTER 41 | 988 | ||
| CHAPTER 42 | 988 | ||
| CHAPTER 43 | 989 | ||
| CHAPTER 44 | 989 | ||
| CHAPTER 45 | 989 | ||
| CHAPTER 46 | 989 | ||
| CHAPTER 47 | 989 | ||
| CHAPTER 48 | 989 | ||
| CHAPTER 49 | 990 | ||
| CHAPTER 50 | 990 | ||
| CHAPTER 51 | 990 | ||
| CHAPTER 52 | 990 | ||
| CHAPTER 53 | 991 | ||
| CHAPTER 54 | 991 | ||
| CHAPTER 55 | 991 | ||
| CHAPTER 56 | 991 | ||
| CHAPTER 57 | 991 | ||
| CHAPTER 58 | 991 |